HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to block HPV cancers missed by current shots
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a new vaccine called RG1-VLP in 18 healthy women aged 18-60. The vaccine targets HPV types not covered by existing vaccines like Gardasil 9. Researchers will check if it is safe and triggers a strong immune response. If it works, it could help prevent…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
Can pharmacy training boost HPV shots and prevent future cancers?
Prevention Recruiting nowThis study looks at whether training pharmacy staff to better communicate about and manage the HPV vaccine can increase vaccination rates in children ages 9-17. About 1,900 participants, including pharmacy staff and parents, will be involved. The goal is to make it easier for fam…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC